Be a Warrior Today,
Exciting News!! Insurance has covered my electronic foot drop system! I have been using a loner system for the past two months and it has been incredible, I'm walking with no cane or braces at all. I'm even gaining strength in my previously gimpish left leg. I will fill everyone in more on the process I used to get it covered in an upcoming blog, I just had to tell everyone!! Fight on!!
Be a Warrior Today,
If you would like to become a blogger, please contact us and let us know!
CLICK ON THE RSS FEED ICON BELOW TO GET A LIST OF ALL OUR PATIENT BLOGS
Important Safety Information
Before beginning treatment, you should discuss the potential benefits and risks associated with Rebif with your healthcare provider.
Rebif can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking Rebif.
Rebif will not cure your MS but may decrease the number of flare-ups of the disease and slow the occurrence of some of the physical disability that is common in people with MS.
Do not take Rebif if you are allergic to interferon beta, human albumin, or any of the ingredients in Rebif.
Before you take Rebif, tell your healthcare provider if you have or have had any of the following conditions:
Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
The most common side effects of Rebif include:
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Rebif. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS.